EnableInsights
Get in touch

Contracts Finder · Award

Hereditary Angioedema

A public procurement published by NHS England via Contracts Finder.

Contracts FinderAward
£74.5m
Award value
£74.5m
Tender value
10
Suppliers
10
Awards
1
Notices
Award
Stage

Overview

NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months

Key details

Buyer
NHS England
Source
Contracts Finder
Lifecycle stage
Award
Status
complete
CPV classification
33600000 — Pharmaceutical products
Currency
GBP
Total award value
£74,500,000
Tender value
£74,500,000
First published
20 Jul 2022
Last updated
20 Jul 2022
View the original notice

Awards

10 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Martindale Pharma—19 Jun 2022active£74.5m
Piramal Critical care Limited0516030619 Jun 2022active£74.5m
CSL Behring UK Ltd0162248319 Jun 2022active£74.5m
Wockhardt UK Limited0583557019 Jun 2022active£74.5m
Cipla—19 Jun 2022active£74.5m
Takeda UK Ltd0336286019 Jun 2022active£74.5m
BioCryst Ireland Limited—19 Jun 2022active£74.5m
Pharming Group—19 Jun 2022active£74.5m
Accord-UK Ltd0007958519 Jun 2022active£74.5m
Celix Pharma Ltd.1247419519 Jun 2022active£74.5m

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award noticeHereditary Angioedema

All suppliers

Frameworks & programmes

More from NHS England

NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025£986.3m
Award · Contracts Finder
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National£261.9m
Award · Contracts Finder
NHS National Generic Pharmaceuticals - Clozapine£1
Award · Contracts Finder
NHS National Generic Pharmaceuticals - Clozapine
Tender · Contracts Finder
NHS National Pharmaceuticals Generic Products Wave 15b
Tender · Contracts Finder
NHS Framework Agreement for Human Albumin & Normal and Anti-D Immunoglobulin£905.2m
Award · Contracts Finder

FAQs about this procurement

Who is the buyer for "Hereditary Angioedema"?

Hereditary Angioedema is a UK public-sector procurement published by NHS England via Contracts Finder.

Has "Hereditary Angioedema" been awarded?

Yes — 10 awards are recorded, with a reported total value of £74,500,000. The current lifecycle stage is "Award".

Which suppliers are involved in "Hereditary Angioedema"?

10 suppliers are linked: Martindale Pharma, Piramal Critical care Limited, CSL Behring UK Ltd, Wockhardt UK Limited, Cipla, Takeda UK Ltd, BioCryst Ireland Limited, Pharming Group.

What is "Hereditary Angioedema" worth?

The reported award value is £74,500,000.

When was "Hereditary Angioedema" published?

It was first published on 20 Jul 2022 and last updated on 20 Jul 2022, across 1 notice.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable